Search Within

MSK Grad Students

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (261)
  2. Journal Article (257)
  3. Research Letter (8)
  4. Miscellaneous (6)
  5. Conference Paper (2)
  6. Correspondence (2)
Groups
  1. Biostatistics Service (536)
  2. Epidemiology and Biostatistics (536)
  3. Department of Medicine (484)
  4. CTCR Scholars (422)
  5. Master of Science in Clinical and Translational Cancer Research (414)
  6. Hematologic Malignancies, Division of (375)

More Groups

People
  1. Sean Devlin (277)
  2. Sergio Giralt (246)
  3. Miguel-Angel Perales (242)
  4. Parastoo Dahi (170)
  5. Doris Ponce (151)
  6. Gunjan Shah (133)

More People

Years
  1. 2025 (19)
  2. 2024 (61)
  3. 2023 (67)
  4. 2022 (63)
  5. 2021 (51)
  6. 2020 (65)

More Years

Publications
  1. Blood (106)
  2. Biology of Blood and Marrow Transplantation (86)
  3. Bone Marrow Transplantation (37)
  4. Annals of Surgical Oncology (32)
  5. Journal of Clinical Oncology (30)
  6. Clinical Cancer Research (22)

More Publications

Publishers
  1. American Society of Hematology (125)
  2. Elsevier Inc. (117)
  3. Nature Publishing Group (77)
  4. Springer (34)
  5. American Association for Cancer Research (33)
  6. American Society of Clinical Oncology (33)

More Publishers

Results (536)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era
    Journal Article

    Bobillo, S.; Joffe, E.; Lavery, J. A.; Sermer, D.; Ghione, P.; Noy, A.; Caron, P. C.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Clinical outcomes of acute myeloid leukemia patients bridged to allogeneic stem cell transplant by venetoclax combination therapy
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; Barker, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • A pilot study evaluating lenalidomide and CC-486 in combination with radiotherapy for patients with plasmacytoma (LENAZART study)
    Meeting Abstract

    Shah, U. A.; Werner, K.; Tavitian, E.; Devlin, S.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Tan, C.; Lu, S. X.; Smith, E. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Secondary graft-versus-host disease (GVHD) prophylaxis with oral proteasome inhibitor ixazomib is associated with low incidence of recurrent, late acute and chronic GVHD and facilitated calcineurin inhibitor taper within the first year post allogeneic stem cell transplantation
    Meeting Abstract

    Rodriguez, N.; Lee, J.; Flynn, L.; Murray, F.; Devlin, S.; Izquierdo, C. S.; Cho, C.; Dahi, P. B.; Giralt, S. A.; Sauter, C. S.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Rabbit anti-thymocyte globulin exposure (rATG) in CD34+ selected hematopoietic cell transplantation and its impact on immune reconstitution and outcomes in children and adults
    Meeting Abstract

    Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jakubowski, A. A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Interim analysis from a prospective multicenter study of next-generation sequencing minimal residual disease assessment and CT monitoring for surveillance after frontline treatment in diffuse large B-cell lymphoma
    Meeting Abstract

    Kumar, A.; Westin, J.; Schuster, S. J.; Nowakowski, G. S.; Lossos, I. S.; Batlevi, C. L.; Caron, P.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical impact of bridging therapy prior to commercial chimeric antigen receptor (CAR) T-cell therapies for relapsed/refractory lymphomas
    Meeting Abstract

    Imber, B. S.; Perales, M. A.; Flynn, J.; Ruiz, J. D.; Devlin, S.; Alarcon Tomas, A.; Hajj, C.; Batlevi, C. L.; Dahi, P. B.; Lin, R. J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Early data from a phase II trial investigating the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S. A.; Ames, A.; Biggar, E.; Moskowitz, A. J.; Batlevi, C. L.; Caron, P.; Hamilton, A. M.; Moskowitz, C. H.; Matasar, M. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Tim-4(+) resident macrophages impair anti-tumor immunity in the serous body cavities by sequestering viable and cytotoxic CD8(+) T cells expressing high levels of phosphatidylserine
    Meeting Abstract

    Chow, A.; Schad, S.; Green, M.; Hellmann, M.; Ceglia, N.; Allaj, V.; Zago, G.; Shah, N.; Sharma, S.; Mattar, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid in vivo functional genomics
    Journal Article

    Hulton, C. H.; Costa, E. A.; Shah, N. S.; Quintanal-Villalonga, A.; Heller, G.; de Stanchina, E.; Rudin, C. M.; Poirier, J. T.
    Nature Cancer (2020)

    Fulltext@MSK | Save